2021
Wang, H., Xie, M., Rizzi, G., Tan, K.# and Fussenegger, M#. Identification of sclareol as a natural neuroprotective Cav1.3-antagonist using Parkinson-mimetic gene circuits and computer-aided drug discovery. Adv Sci (2021), 9(7):2102855.
Strittmatter, T., Egli, S., Bertschi, A., Plieninger, R., Bojar, D., Xie, M. and Fussenegger, M. Gene switch for L-glucose-induced biopharmaceutical production in mammalian cells. Biotechnol Bioeng (2021) 118(6):2220.
Shao, J., Qiu, X. and Xie, M.# Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol (2021) 2312:35.
2020
Xie, M.#, Viviani, M. and Fussenegger, M.# Engineering Precision Therapies: Lessons and Motivations from the Clinic. Synth Biol (2020) 6(1):ysaa024.
Xie, M.# and Lu, P.# When de novo-designed protein logics meet CAR-T therapies. Cell Res (2020) 30(11):946.
Xie, M. and Fussenegger, M.# Designing cell function: assembly of synthetic gene circuits for cell-biology applications. Nat Rev Mol Cell Biol (2018) 19(8):507.
Krawczyk, K., Xue, S., Buchmann, P., Charpin-El Hamri, G., Saxena, P., Hussherr, M.-D., Shao, J., Ye, H., Xie, M., and Fussenegger, M.# Electrogenet6ic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science (2020) 368(6494):993.
9Meyer, C., Liu, J., Craciun, I., Wu, D., Wang, H., Xie, M., Fussenegger, M., and Palivan, C.# Segregated Nanocompartments Containing Therapeutic Enzymes and Imaging Compounds Within DNA-Zipped Polymersome Clusters for Advanced Nanotheranostic Platform. Small (2020) 16(27):e1906492.
2019
Bai, P., Liu, Y., Xue, S., Charpin-El Hamri, G., Saxena, P., Ye, H., Xie, M., and Fussenegger, M.# A fully human transgene switch to regulate therapeutic protein production by cooling sensation. Nat Med (2019) 25(8):1266.
2018
Wang, H., Xie, M., Charpin-El Hamri, G., Ye, H. and Fussenegger, M.# Treatment of chronic pain by designer cells controlled by spearmint aromatherapy. Nat Biomed Eng (2018) 2(2):114.